CTWCTW
Price$1.94Intrinsic value$2.1913% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $90.4M+32.1% YoYTTM through 31 Jul 2025
Net Income $3.8M-36.0% YoYTTM through 31 Jul 2025
Free Cash Flow -$473.3KTTM through 31 Jul 2025

Margins

Current
EBITDA Margin1.8%
Operating Margin-1.2%
Net Margin4.2%

Returns

13.8%ROE
8.2%ROA

Balance Sheet Health

Debt / Equity0.20x
Current Ratio2.15x
Net Debt-$90.5Mnet cash position
Cash & Equivalents$12.2M

Quality Metrics

Altman Z-Score7.29
Piotroski F-Score5 / 9
FCF Margin-0.5%

Multi-Year Trend

Revenue
'23'24'25
FY2025: $90.4M
Diluted EPS$0.06TTM
'23'24'25
FY2025: $0.06

Dividend

No dividend

Capital Allocation

R&D Spend$5.5M
Capex Intensity0.6%

Segment Performance

No segment data available.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.